Skip to main content
Premium Trial:

Request an Annual Quote

Canada s Virtek Sells Microarray Business to Bio-Rad

NEW YORK, June 28--Bio-Rad bought the microarray division of the Canadian laser and automation company Virtek Vision for more than C$10 million (US $6.6 million), Virtek said today.


Bio-Rad will obtain all property related to Virtek's ChipReader microarray scanner, its ChipWriter Pro spotter, and its arraying and picking systems.


Bio-Rad will establish a new microarray and automation business unit in Virek's operations center in Waterloo, Ontario, and has hired Virtek's employees to continue developing the microarray technology.

More specific financial details of the transaction were not available.


Bio-Rad is a major manufacturer of lab products and clinical diagnostics based in Hercules, Calif.


Virtek develops lasers for a range of industries. The company has been seeking a purchaser for its microarray division for four months, in an effort to return to profitability.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.